Archives of Clinical Infectious Diseases

Published by: Kowsar

The Utilization of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Cardiovascular Implantable Electronic Device Infections in Case of a Negative Transesophageal Echocardiogram

Trine Kiilerich Lauridsen 1 , * , Bente Krogsgaard Schaadt 2 , Elisabeth Albrecht-Beste 2 and Niels Eske Bruun 1
Authors Information
1 Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark
2 Department of Radiology and Clinical Physiology and Nuclear Medicine, Gentofte University Hospital, Copenhagen, Denmark
Article information
  • Archives of Clinical Infectious Diseases: October 01, 2016, 11 (4); e34586
  • Published Online: August 22, 2016
  • Article Type: Case Report
  • Received: November 11, 2015
  • Revised: August 15, 2016
  • Accepted: August 17, 2016
  • DOI: 10.5812/archcid.34586

To Cite: Kiilerich Lauridsen T, Krogsgaard Schaadt B, Albrecht-Beste E, Eske Bruun N. The Utilization of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Cardiovascular Implantable Electronic Device Infections in Case of a Negative Transesophageal Echocardiogram, Arch Clin Infect Dis. 2016 ; 11(4):e34586. doi: 10.5812/archcid.34586.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol. 2006; 48(3): 590-1[DOI][PubMed]
  • 2. Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010; 121(3): 458-77[DOI][PubMed]
  • 3. Athan E, Chu VH, Tattevin P, Selton-Suty C, Jones P, Naber C, et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA. 2012; 307(16): 1727-35[DOI][PubMed]
  • 4. de Bie MK, van Rees JB, Thijssen J, Borleffs CJ, Trines SA, Cannegieter SC, et al. Cardiac device infections are associated with a significant mortality risk. Heart Rhythm. 2012; 9(4): 494-8[DOI][PubMed]
  • 5. Klug D, Wallet F, Lacroix D, Marquie C, Kouakam C, Kacet S, et al. Local symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart. 2004; 90(8): 882-6[DOI][PubMed]
  • 6. Bruun NE, Egeblad H, Elming H, Fuursted K, Gill S, Hassager C, et al. Danish society of cardiology, guidelines on infective endocarditis. 2012;
  • 7. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VJ, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000; 30(4): 633-8[DOI][PubMed]
  • 8. Downey BC, Juselius WE, Pandian NG, Estes N3, Link MS. Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography. Pacing Clin Electrophysiol. 2011; 34(6): 679-83[DOI][PubMed]
  • 9. Bruun NE, Habib G, Thuny F, Sogaard P. Cardiac imaging in infectious endocarditis. Eur Heart J. 2014; 35(10): 624-32[DOI][PubMed]
  • 10. Bailey DL, Willowson KP. An evidence-based review of quantitative SPECT imaging and potential clinical applications. J Nucl Med. 2013; 54(1): 83-9[DOI][PubMed]
  • 11. Thomson LE, Goodman MP, Naqvi TZ, Feldman R, Buchbinder NA, Waxman A, et al. Aortic root infection in a prosthetic valve demonstrated by gallium-67 citrate SPECT. Clin Nucl Med. 2005; 30(4): 265-8[PubMed]
  • 12. Schiavo R, Ricci A, Pontillo D, Bernardini G, Melacrinis FF, Maccafeo S. Implantable cardioverter-defibrillator lead infection detected by 99mTc-sulesomab single-photon emission computed tomography/computed tomography 'fusion' imaging. J Cardiovasc Med (Hagerstown). 2009; 10(11): 883-4[DOI][PubMed]
  • 13. Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012; 59(18): 1616-25[DOI][PubMed]
  • 14. Balink H, Collins J, Bruyn GA, Gemmel F. F-18 FDG PET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med. 2009; 34(12): 862-8[DOI][PubMed]
  • 15. Johansen JB, Jorgensen OD, Moller M, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J. 2011; 32(8): 991-8[DOI][PubMed]
  • 16. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004; 350(14): 1422-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments